24 related articles for article (PubMed ID: 9264242)
1. Benzotriazole: An overview on its versatile biological behavior.
Briguglio I; Piras S; Corona P; Gavini E; Nieddu M; Boatto G; Carta A
Eur J Med Chem; 2015 Jun; 97():612-48. PubMed ID: 25293580
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth.
Chagas-Silva F; Nascimento-Viana JB; Romeiro LA; Barberato LC; Noël F; Silva CL
Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):225-34. PubMed ID: 24213881
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-adrenoceptor antagonists. 6. Structural optimization of pyridazinone-arylpiperazines. Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety.
Betti L; Corelli F; Floridi M; Giannaccini G; Maccari L; Manetti F; Strappaghetti G; Botta M
J Med Chem; 2003 Jul; 46(16):3555-8. PubMed ID: 12877594
[TBL] [Abstract][Full Text] [Related]
6. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of CNS agents, Part 32: Effect of structural modifications in 1-arylpiperazine derivatives on alpha(1) -adrenoreceptor affinity.
Mokrosz MJ; Paluchowska MH; Charakchieva-Minol S; Bień A
Arch Pharm (Weinheim); 1997 Jun; 330(6):177-80. PubMed ID: 9264242
[TBL] [Abstract][Full Text] [Related]
9. A synthetic overview of new molecules with 5-HT1A binding affinities.
Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
[TBL] [Abstract][Full Text] [Related]
10. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.
Rague A; Tidgewell K
Mini Rev Med Chem; 2018; 18(7):552-560. PubMed ID: 28901854
[TBL] [Abstract][Full Text] [Related]
12. Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment.
Hoerr R; Noeldner M
CNS Drug Rev; 2002; 8(2):143-58. PubMed ID: 12177685
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
